NSE: NIVABUPA | BSE: 544286

Slowing Down Stock

Download real time

73.48 -0.93 (-1.25%)

25.94% Fall from 52W High

646.9K NSE+BSE Volume

NSE 05 Dec, 2025 3:31 PM (IST)

13,565.7

Market Cap

Beta 1Year

Very Low volatility

Niva Bupa Health Insurance Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NIVABUPA, BSE:544286 Niva Bupa Health Insurance Company Ltd.

Search Inside the pdf :

Niva Bupa Health Insurance Company Ltd.

06 Nov 2025, 12:00AM

73.48

-1.25%

Accelerated volume growth – a positive; managing GST cost impact key earnings determinant

Buy: Niva Bupa Health Insurance...

Target

ICICI Securities Limited

The impact of GST rate cuts on margins driven by the unavailability of input tax credit has been a key concern for investors. Towards that end, Niva Bupa clarified to have passed on the impact to distributors, while volume growth has accelerated (more than 50% new business growth and 100bps renewal rate increase in retail segment during Oct’25).

Number of FII/FPI investors decreased from 80 to 73 in Sep 2025 qtr

Niva Bupa Health Insurance Company Ltd.

05 Nov 2025, 12:00AM

73.48

-1.25%

Strong revenue traction; opex elevated

ipo note: Niva Bupa Health Insurance...

Motilal Oswal

CDSL’s operating revenue declined 1% YoY but grew 23% QoQ to INR3.2b (7% beat) in 2QFY26. The sequential growth was propelled by a 195% growth in IPO & corporate action charges and 28% growth in online data charges.

Number of FII/FPI investors decreased from 80 to 73 in Sep 2025 qtr

Niva Bupa Health Insurance Company Ltd.

03 Nov 2025

73.48

-1.25%

Strong revenue traction; opex elevated

ipo note: Niva Bupa Health Insurance...

Motilal Oswal

Niva Bupa Health Insurance Company Ltd. is trading below all available SMAs

Niva Bupa Health Insurance Company Ltd.

03 Nov 2025

73.48

-1.25%

Combined ratio hit by higher opex and claims

Buy: Niva Bupa Health Insurance...

Target

Motilal Oswal

Niva Bupa (Niva) reported 17% YoY growth in NEP to INR14.2b (in-line) in 2QFY26. For 1HFY25, NEP grew 18% YoY to INR26.4b.

Niva Bupa Health Insurance has lost -26.52% in the last 1 Year

Niva Bupa Health Insurance Company Ltd.

11 Aug 2025

73.48

-1.25%

Premium and earnings growth remain strong under IFRS

Buy: Niva Bupa Health Insurance...

Target

ICICI Securities Limited

Niva Bupa has been able to deliver standout growth in health insurance premiums (~40% CAGR between FY20–25 and 28% in Q1FY26 on a comparable basis (without 1/n).

Niva Bupa Health Ins.. has an average target of 91.00 from 2 brokers.

Niva Bupa Health Insurance Company Ltd.

07 Aug 2025

73.48

-1.25%

Sharpening the moat

Buy: Niva Bupa Health Insurance...

Motilal Oswal

We initiated coverage on Niva Bupa in Apr’25 highlighting the faster-thanindustry growth momentum, product innovation capabilities, high standards of customer servicing and its focus on strengthening profitability.

Niva Bupa Health Insurance has lost -26.52% in the last 1 Year

Niva Bupa Health Insurance Company Ltd.

31 Jul 2025

73.48

-1.25%

Elevated claims ratio hits profitability

Buy: Niva Bupa Health Insurance...

Target

Motilal Oswal

Niva Bupa posted a 20% YoY growth in NEP to INR12.2b (in line) in 1QFY26. The loss ratio at 77.9% (our est. of 72.3%) increased 1,390bp YoY due to the impact of 1/n, higher reserving led by suspension of auto adjudication of claims.

Niva Bupa Health Insurance has lost -26.52% in the last 1 Year

Niva Bupa Health Insurance Company Ltd.

23 Apr 2025

73.48

-1.25%

Citius, Altius, Fortius!

Buy: Niva Bupa Health Insurance...

Motilal Oswal

Niva Bupa Health Insurance (Niva) has emerged as one of the fastest-growing health insurers, delivering a CAGR of ~34% during FY22-25 and garnering the highest incremental market share in the retail health segment.

Number of FII/FPI investors decreased from 80 to 73 in Sep 2025 qtr

Niva Bupa Health Insurance Company Ltd.

15 Apr 2025

73.48

-1.25%

Strong execution delivering sector-leading performance

Buy: Niva Bupa Health Insurance...

ICICI Securities Limited

Niva Bupa has been able to deliver standout growth in health insurance premiums (~40% CAGR between FY20-25) while its improved scale and assets under management should help improve margins and earnings growth ahead (expect IFRS PAT CAGR of 53% over FY25-27E).